Biotechnology
The Biotechnology industry has a total of 591 stocks, with a combined market cap of $1.2 trillion and total revenue of $110.17 billion.
Market Cap
1.2T
Revenue
110.17B
Profits
-39.86B
PE Ratio
n/a
Profit Margin
-36.18%
Dividend Yield
0.04%
591 Stocks
| No. | Symbol | Company Name | Market Cap | % Change | Volume | Revenue |
|---|---|---|---|---|---|---|
| 1 | VRTX | Vertex Pharmaceuticals Incorporated | 112.22B | 1.27% | 1,025,317 | 12.00B |
| 2 | REGN | Regeneron Pharmaceuticals, Inc. | 77.02B | 0.61% | 512,955 | 14.34B |
| 3 | ARGX | argenx SE | 52.70B | 2.50% | 235,928 | 4.24B |
| 4 | ALNY | Alnylam Pharmaceuticals, Inc. | 41.07B | -3.27% | 1,495,470 | 3.71B |
| 5 | ONC | BeOne Medicines AG | 35.92B | 0.99% | 206,312 | 5.34B |
| 6 | RVMD | Revolution Medicines, Inc. | 31.26B | -0.43% | 4,759,354 | - |
| 7 | INSM | Insmed Incorporated | 31.19B | 1.18% | 2,048,418 | 606.42M |
| 8 | RPRX | Royalty Pharma plc | 29.64B | 3.14% | 3,036,224 | 2.38B |
| 9 | BNTX | BioNTech SE | 26.03B | 0.78% | 777,359 | 3.37B |
| 10 | ROIV | Roivant Sciences Ltd. | 21.35B | 2.19% | 6,502,945 | 13.31M |
| 11 | MRNA | Moderna, Inc. | 21.30B | -1.76% | 13,574,610 | 1.94B |
| 12 | SMMT | Summit Therapeutics Inc. | 19.50B | 2.99% | 4,899,834 | - |
| 13 | INCY | Incyte Corporation | 19.47B | 2.62% | 1,529,408 | 5.14B |
| 14 | GMAB | Genmab A/S | 17.49B | 0.88% | 2,194,868 | 3.72B |
| 15 | ASND | Ascendis Pharma A/S | 15.10B | 0.63% | 374,402 | 845.52M |
| 16 | BBIO | BridgeBio Pharma, Inc. | 14.88B | -0.98% | 2,044,777 | 502.08M |
| 17 | JAZZ | Jazz Pharmaceuticals plc | 12.52B | 2.83% | 634,761 | 4.27B |
| 18 | IONS | Ionis Pharmaceuticals, Inc. | 12.51B | 0.60% | 1,719,445 | 943.71M |
| 19 | MDGL | Madrigal Pharmaceuticals, Inc. | 12.20B | 1.38% | 341,215 | 958.40M |
| 20 | EXEL | Exelixis, Inc. | 11.66B | 1.15% | 2,495,856 | 2.32B |
| 21 | BMRN | BioMarin Pharmaceutical Inc. | 10.51B | 1.00% | 2,070,568 | 3.22B |
| 22 | ABVX | ABIVAX Société Anonyme | 9.79B | -1.89% | 1,178,885 | 5.37M |
| 23 | ARWR | Arrowhead Pharmaceuticals, Inc. | 9.73B | 2.25% | 4,332,000 | 1.09B |
| 24 | AXSM | Axsome Therapeutics, Inc. | 9.67B | 2.61% | 767,408 | 638.50M |
| 25 | PRAX | Praxis Precision Medicines, Inc. | 9.54B | 6.90% | 425,200 | 7.46M |
| 26 | TECH | Bio-Techne Corporation | 9.27B | 3.26% | 1,924,845 | 1.22B |
| 27 | PCVX | Vaxcyte, Inc. | 8.97B | 0.24% | 1,151,529 | - |
| 28 | NUVL | Nuvalent, Inc. | 8.46B | 3.61% | 772,509 | - |
| 29 | CYTK | Cytokinetics, Incorporated | 8.22B | 1.97% | 1,498,973 | 88.04M |
| 30 | HALO | Halozyme Therapeutics, Inc. | 8.21B | 3.98% | 1,674,188 | 1.40B |
| 31 | KRYS | Krystal Biotech, Inc. | 8.07B | 3.84% | 327,185 | 389.13M |
| 32 | IBRX | ImmunityBio, Inc. | 7.95B | 6.21% | 21,520,141 | 113.29M |
| 33 | KYMR | Kymera Therapeutics, Inc. | 7.16B | 1.82% | 587,341 | 39.21M |
| 34 | APGE | Apogee Therapeutics, Inc. | 6.81B | 1.82% | 1,229,251 | - |
| 35 | PTGX | Protagonist Therapeutics, Inc. | 6.76B | 2.17% | 1,006,314 | 46.02M |
| 36 | ACLX | Arcellx, Inc. | 6.75B | -0.04% | 479,537 | 22.29M |
| 37 | BLTE | Belite Bio, Inc | 6.51B | 4.68% | 171,752 | - |
| 38 | SYRE | Spyre Therapeutics, Inc. | 6.30B | 4.75% | 2,126,322 | - |
| 39 | CGON | CG Oncology, Inc. | 6.20B | 10.69% | 1,765,208 | 4.04M |
| 40 | CNTA | Centessa Pharmaceuticals plc | 6.13B | 0.33% | 3,773,801 | 15.00M |
| 41 | TERN | Terns Pharmaceuticals, Inc. | 6.08B | -0.08% | 6,389,287 | - |
| 42 | RYTM | Rhythm Pharmaceuticals, Inc. | 6.06B | 0.66% | 688,556 | 189.76M |
| 43 | COGT | Cogent Biosciences, Inc. | 6.00B | 2.93% | 3,948,341 | - |
| 44 | PTCT | PTC Therapeutics, Inc. | 6.00B | 1.02% | 1,500,435 | 1.73B |
| 45 | CAI | Caris Life Sciences, Inc. | 5.98B | 3.68% | 1,121,855 | 812.03M |
| 46 | IMVT | Immunovant, Inc. | 5.96B | 7.13% | 3,421,821 | - |
| 47 | CELC | Celcuity Inc. | 5.92B | -2.23% | 492,503 | - |
| 48 | MIRM | Mirum Pharmaceuticals, Inc. | 5.91B | 2.18% | 469,968 | 521.31M |
| 49 | ERAS | Erasca, Inc. | 5.91B | 4.28% | 5,255,372 | - |
| 50 | SRRK | Scholar Rock Holding Corporation | 5.74B | -0.08% | 1,757,568 | - |
| 51 | XENE | Xenon Pharmaceuticals Inc. | 5.70B | 2.17% | 872,229 | 7.50M |
| 52 | CRSP | CRISPR Therapeutics AG | 5.57B | 4.07% | 1,801,349 | 3.51M |
| 53 | APLS | Apellis Pharmaceuticals, Inc. | 5.23B | 0.07% | 5,216,649 | 1.00B |
| 54 | TGTX | TG Therapeutics, Inc. | 5.22B | 3.00% | 2,607,357 | 616.29M |
| 55 | DNTH | Dianthus Therapeutics, Inc. | 5.08B | 0.39% | 553,118 | 2.04M |
| 56 | CORT | Corcept Therapeutics Incorporated | 4.91B | 5.00% | 1,734,972 | 761.41M |
| 57 | LGND | Ligand Pharmaceuticals Incorporated | 4.62B | 3.84% | 168,959 | 268.09M |
| 58 | FOLD | Amicus Therapeutics, Inc. | 4.54B | 0.07% | 2,211,335 | 634.21M |
| 59 | CRNX | Crinetics Pharmaceuticals, Inc. | 4.29B | 5.07% | 1,102,050 | 7.70M |
| 60 | VKTX | Viking Therapeutics, Inc. | 4.08B | -0.87% | 2,478,528 | - |
| 61 | NAMS | NewAmsterdam Pharma Company N.V. | 3.99B | 4.46% | 648,342 | 22.50M |
| 62 | LEGN | Legend Biotech Corporation | 3.92B | 0.43% | 1,809,094 | 1.03B |
| 63 | TNGX | Tango Therapeutics, Inc. | 3.80B | 6.39% | 2,907,856 | 62.38M |
| 64 | ACAD | ACADIA Pharmaceuticals Inc. | 3.78B | 4.33% | 8,552,530 | 1.07B |
| 65 | TVTX | Travere Therapeutics, Inc. | 3.77B | 3.11% | 2,057,367 | 490.73M |
| 66 | EWTX | Edgewise Therapeutics, Inc. | 3.69B | 3.96% | 824,019 | - |
| 67 | GPCR | Structure Therapeutics Inc. | 3.60B | -5.14% | 916,770 | - |
| 68 | TLX | Telix Pharmaceuticals Limited | 3.57B | - | 301,044 | 803.79M |
| 69 | ORKA | Oruka Therapeutics, Inc. | 3.41B | 2.76% | 1,376,640 | - |
| 70 | DYN | Dyne Therapeutics, Inc. | 3.37B | 2.51% | 2,674,162 | - |
| 71 | DNLI | Denali Therapeutics Inc. | 3.26B | -0.68% | 1,461,979 | - |
| 72 | CPRX | Catalyst Pharmaceuticals, Inc. | 3.21B | 1.43% | 3,279,195 | 588.99M |
| 73 | ALMS | Alumis Inc. | 3.18B | -0.04% | 1,179,172 | 24.05M |
| 74 | BEAM | Beam Therapeutics Inc. | 3.12B | 3.49% | 1,944,182 | 139.74M |
| 75 | KLRA | Kailera Therapeutics, Inc. | 3.07B | 62.50% | 8,114,314 | - |
| 76 | ARQT | Arcutis Biotherapeutics, Inc. | 3.04B | 1.41% | 1,158,462 | 376.07M |
| 77 | RCUS | Arcus Biosciences, Inc. | 3.04B | 2.80% | 695,671 | 247.00M |
| 78 | VERA | Vera Therapeutics, Inc. | 3.03B | 0.14% | 1,168,147 | - |
| 79 | RLAY | Relay Therapeutics, Inc. | 3.00B | 4.03% | 2,360,651 | 15.36M |
| 80 | IDYA | IDEAYA Biosciences, Inc. | 2.98B | 4.31% | 1,613,402 | 218.71M |
| 81 | ELVN | Enliven Therapeutics, Inc. | 2.88B | 6.11% | 1,383,702 | - |
| 82 | TARS | Tarsus Pharmaceuticals, Inc. | 2.86B | -0.71% | 852,904 | 451.36M |
| 83 | MANE | Veradermics, Incorporated | 2.85B | 2.93% | 261,265 | - |
| 84 | IMNM | Immunome, Inc. | 2.79B | 5.89% | 1,022,198 | 6.94M |
| 85 | KOD | Kodiak Sciences Inc. | 2.77B | 11.11% | 1,040,569 | - |
| 86 | IRON | Disc Medicine, Inc. | 2.74B | 3.34% | 456,912 | - |
| 87 | SLNO | Soleno Therapeutics, Inc. | 2.73B | 0.40% | 3,948,770 | 190.41M |
| 88 | ZLAB | Zai Lab Limited | 2.73B | 2.94% | 1,451,683 | 460.16M |
| 89 | CLDX | Celldex Therapeutics, Inc. | 2.71B | 2.04% | 1,481,146 | 1.55M |
| 90 | ADMA | ADMA Biologics, Inc. | 2.62B | 2.51% | 20,233,996 | 510.17M |
| 91 | MLYS | Mineralys Therapeutics, Inc. | 2.52B | 0.07% | 1,036,915 | - |
| 92 | AAPG | Ascentage Pharma Group International | 2.48B | 0.88% | 1,811 | 82.08M |
| 93 | NKTR | Nektar Therapeutics | 2.43B | 1.04% | 507,922 | 55.23M |
| 94 | RARE | Ultragenyx Pharmaceutical Inc. | 2.43B | 1.18% | 1,725,498 | 673.00M |
| 95 | SRPT | Sarepta Therapeutics, Inc. | 2.26B | 1.79% | 2,511,892 | 2.20B |
| 96 | DFTX | Definium Therapeutics, Inc. | 2.26B | 0.98% | 2,122,149 | - |
| 97 | ADPT | Adaptive Biotechnologies Corporation | 2.23B | 2.77% | 1,592,692 | 276.98M |
| 98 | DAWN | Day One Biopharmaceuticals, Inc. | 2.22B | 0.09% | 2,241,399 | 158.18M |
| 99 | STOK | Stoke Therapeutics, Inc. | 2.20B | 5.46% | 894,293 | 184.42M |
| 100 | OCUL | Ocular Therapeutix, Inc. | 2.14B | 10.84% | 5,312,575 | 51.95M |
| 101 | SNDX | Syndax Pharmaceuticals, Inc. | 2.14B | 1.76% | 1,660,317 | 172.35M |
| 102 | AUPH | Aurinia Pharmaceuticals Inc. | 2.13B | 1.39% | 754,507 | 283.06M |
| 103 | MESO | Mesoblast Limited | 2.09B | 2.30% | 163,751 | 65.38M |
| 104 | AGIO | Agios Pharmaceuticals, Inc. | 2.06B | 0.63% | 673,042 | 54.03M |
| 105 | ZYME | Zymeworks Inc. | 2.05B | 2.21% | 487,203 | 105.97M |
| 106 | CAPR | Capricor Therapeutics, Inc. | 2.01B | 0.32% | 773,138 | 11.13M |
| 107 | RXRX | Recursion Pharmaceuticals, Inc. | 2.00B | 5.00% | 14,319,041 | 74.68M |
| 108 | SION | Sionna Therapeutics, Inc. | 1.96B | -3.76% | 508,774 | - |
| 109 | TRVI | Trevi Therapeutics, Inc. | 1.96B | 4.75% | 7,258,604 | - |
| 110 | ANAB | AnaptysBio, Inc. | 1.94B | 0.91% | 623,861 | 234.60M |
| 111 | GLPG | Galapagos NV | 1.92B | 1.46% | 91,081 | 1.31B |
| 112 | TYRA | Tyra Biosciences, Inc. | 1.92B | 1.25% | 1,346,053 | - |
| 113 | RAPP | Rapport Therapeutics, Inc. | 1.90B | 0.43% | 1,667,112 | - |
| 114 | PHVS | Pharvaris N.V. | 1.87B | -0.76% | 149,201 | - |
| 115 | PVLA | Palvella Therapeutics, Inc. | 1.86B | 4.69% | 303,744 | - |
| 116 | TSHA | Taysha Gene Therapies, Inc. | 1.85B | 8.07% | 6,165,259 | 9.77M |
| 117 | VCEL | Vericel Corporation | 1.82B | 5.66% | 441,121 | 276.26M |
| 118 | NRIX | Nurix Therapeutics, Inc. | 1.81B | 4.91% | 853,412 | 71.78M |
| 119 | INVA | Innoviva, Inc. | 1.80B | 2.71% | 683,936 | 411.33M |
| 120 | NUVB | Nuvation Bio Inc. | 1.77B | 5.61% | 2,720,654 | 62.90M |
| 121 | NTLA | Intellia Therapeutics, Inc. | 1.77B | 5.58% | 3,086,412 | 67.67M |
| 122 | HRMY | Harmony Biosciences Holdings, Inc. | 1.74B | 1.94% | 670,851 | 868.45M |
| 123 | VIR | Vir Biotechnology, Inc. | 1.72B | 4.07% | 2,354,984 | 68.56M |
| 124 | BHVN | Biohaven Ltd. | 1.65B | 9.69% | 2,694,690 | - |
| 125 | NBTX | Nanobiotix S.A. | 1.64B | 4.10% | 60,543 | 38.27M |
| 126 | OCS | Oculis Holding AG | 1.62B | 0.33% | 366,236 | 1.51M |
| 127 | MBX | MBX Biosciences, Inc. | 1.60B | 1.66% | 304,632 | - |
| 128 | DMRA | Damora Therapeutics, Inc. | 1.60B | -1.48% | 388,890 | - |
| 129 | IMCR | Immunocore Holdings plc | 1.59B | 0.22% | 799,898 | 400.02M |
| 130 | IOVA | Iovance Biotherapeutics, Inc. | 1.59B | 1.58% | 10,684,185 | 263.50M |
| 131 | GENB | Generate Biomedicines, Inc. | 1.59B | -1.27% | 270,953 | 31.89M |
| 132 | GLUE | Monte Rosa Therapeutics, Inc. | 1.58B | 5.78% | 890,611 | 123.67M |
| 133 | ARDX | Ardelyx, Inc. | 1.58B | 2.71% | 3,360,970 | 407.32M |
| 134 | BCAX | Bicara Therapeutics Inc. | 1.57B | 0.33% | 467,153 | - |
| 135 | VRDN | Viridian Therapeutics, Inc. | 1.51B | 0.95% | 1,582,032 | 70.85M |
| 136 | IMTX | Immatics N.V. | 1.50B | 2.76% | 358,277 | 56.67M |
| 137 | ATAI | AtaiBeckley Inc. | 1.47B | -1.47% | 5,768,247 | 4.09M |
| 138 | OLMA | Olema Pharmaceuticals, Inc. | 1.47B | 2.06% | 800,345 | - |
| 139 | SVRA | Savara Inc. | 1.47B | 2.48% | 1,719,075 | - |
| 140 | NVAX | Novavax, Inc. | 1.44B | 2.31% | 2,421,783 | 1.12B |
| 141 | WVE | Wave Life Sciences Ltd. | 1.41B | 2.32% | 5,957,241 | 42.73M |
| 142 | PGEN | Precigen, Inc. | 1.41B | 0.76% | 2,504,425 | 9.68M |
| 143 | CRVS | Corvus Pharmaceuticals, Inc. | 1.41B | 11.30% | 2,521,153 | - |
| 144 | MAZE | Maze Therapeutics, Inc. | 1.40B | 4.54% | 1,371,030 | 2.50M |
| 145 | MPLT | MapLight Therapeutics, Inc. | 1.32B | 5.40% | 226,776 | - |
| 146 | MLTX | MoonLake Immunotherapeutics | 1.32B | 3.09% | 858,333 | - |
| 147 | AVBP | ArriVent BioPharma, Inc. | 1.31B | 0.10% | 397,662 | - |
| 148 | ZBIO | Zenas BioPharma, Inc. | 1.30B | 0.30% | 316,944 | 10.00M |
| 149 | INBX | Inhibrx Biosciences, Inc. | 1.29B | 6.16% | 416,564 | 1.30M |
| 150 | DBVT | DBV Technologies S.A. | 1.27B | 3.54% | 236,644 | 5.64M |
| 151 | EYPT | EyePoint, Inc. | 1.25B | 0.81% | 1,264,319 | 31.37M |
| 152 | PHAR | Pharming Group N.V. | 1.24B | 0.06% | 7,021 | 376.13M |
| 153 | ABCL | AbCellera Biologics Inc. | 1.22B | 4.70% | 4,808,595 | 75.13M |
| 154 | IVA | Inventiva S.A. | 1.18B | 0.71% | 446,889 | 7.94M |
| 155 | SEPN | Septerna, Inc. | 1.17B | 4.56% | 391,394 | 45.95M |
| 156 | GHRS | GH Research PLC | 1.14B | 3.38% | 139,385 | - |
| 157 | JBIO | Jade Biosciences, Inc. | 1.13B | 4.43% | 703,949 | - |
| 158 | AKTS | Aktis Oncology, Inc. | 1.12B | 8.87% | 205,250 | 6.50M |
| 159 | QURE | uniQure N.V. | 1.10B | 4.58% | 1,903,042 | 16.10M |
| 160 | XERS | Xeris Biopharma Holdings, Inc. | 1.10B | 4.08% | 1,246,142 | 291.85M |
| 161 | URGN | UroGen Pharma Ltd. | 1.10B | 5.38% | 602,779 | 109.79M |
| 162 | CMPX | Compass Therapeutics, Inc. | 1.08B | -8.12% | 3,732,115 | 850.00K |
| 163 | ORIC | ORIC Pharmaceuticals, Inc. | 1.08B | 5.08% | 1,747,063 | - |
| 164 | GERN | Geron Corporation | 1.08B | -0.59% | 23,705,606 | 183.88M |
| 165 | ANNX | Annexon, Inc. | 1.05B | 3.32% | 3,001,191 | - |
| 166 | KALV | KalVista Pharmaceuticals, Inc. | 1.05B | 4.70% | 1,091,385 | 73.62M |
| 167 | PHAT | Phathom Pharmaceuticals, Inc. | 1.05B | 4.60% | 922,615 | 175.11M |
| 168 | CTMX | CytomX Therapeutics, Inc. | 1.04B | -1.43% | 4,939,243 | 76.20M |
| 169 | EVMN | Evommune, Inc. | 988.70M | 2.54% | 234,648 | 13.00M |
| 170 | ANRO | Alto Neuroscience, Inc. | 971.66M | 6.37% | 337,303 | - |
| 171 | FTRE | Fortrea Holdings Inc. | 970.53M | 2.73% | 750,058 | 2.72B |
| 172 | OMER | Omeros Corporation | 967.63M | 7.18% | 1,950,399 | - |
| 173 | JANX | Janux Therapeutics, Inc. | 962.36M | 4.15% | 1,148,090 | 10.00M |
| 174 | XNCR | Xencor, Inc. | 957.80M | 4.90% | 877,127 | 125.58M |
| 175 | SANA | Sana Biotechnology, Inc. | 939.37M | 1.44% | 3,259,467 | - |
| 176 | SLS | SELLAS Life Sciences Group, Inc. | 937.42M | 5.88% | 6,051,447 | - |
| 177 | MGTX | MeiraGTx Holdings plc | 936.68M | 6.75% | 2,283,256 | 81.39M |
| 178 | ABUS | Arbutus Biopharma Corporation | 922.66M | 0.85% | 1,052,579 | 14.08M |
| 179 | CGEM | Cullinan Therapeutics, Inc. | 911.52M | 2.17% | 841,381 | - |
| 180 | VOR | Vor Biopharma Inc. | 898.94M | 10.82% | 2,149,420 | - |
| 181 | TBPH | Theravance Biopharma, Inc. | 887.22M | 2.68% | 436,111 | 107.46M |
| 182 | DRUG | Bright Minds Biosciences Inc. | 884.14M | 1.41% | 115,200 | - |
| 183 | MNKD | MannKind Corporation | 876.98M | 3.27% | 3,534,742 | 348.97M |
| 184 | LBRX | LB Pharmaceuticals Inc | 875.16M | 7.92% | 341,535 | - |
| 185 | MRVI | Maravai LifeSciences Holdings, Inc. | 871.46M | -0.59% | 2,726,511 | 185.74M |
| 186 | KURA | Kura Oncology, Inc. | 859.22M | 8.28% | 3,580,689 | 67.48M |
| 187 | SLDB | Solid Biosciences Inc. | 849.15M | 2.86% | 976,996 | - |
| 188 | SGP | SpyGlass Pharma, Inc. | 833.66M | -0.36% | 43,789 | - |
| 189 | FBRX | Forte Biosciences, Inc. | 830.30M | 7.92% | 445,365 | - |
| 190 | ALLO | Allogene Therapeutics, Inc. | 822.11M | 0.84% | 11,548,755 | 22.00K |
| 191 | SPRY | ARS Pharmaceuticals, Inc. | 812.25M | - | 1,276,355 | 84.28M |
| 192 | DSGN | Design Therapeutics, Inc. | 809.14M | 5.08% | 302,597 | - |
| 193 | LXRX | Lexicon Pharmaceuticals, Inc. | 792.28M | 1.63% | 3,112,875 | 49.80M |
| 194 | RLMD | Relmada Therapeutics, Inc. | 784.56M | 6.86% | 2,384,568 | - |
| 195 | BBOT | BridgeBio Oncology Therapeutics, Inc. | 748.31M | 1.41% | 586,321 | - |
| 196 | GYRE | Gyre Therapeutics, Inc. | 739.64M | 2.53% | 89,959 | 116.59M |
| 197 | TENX | Tenax Therapeutics, Inc. | 726.84M | 7.20% | 764,310 | - |
| 198 | CBIO | Crescent Biopharma, Inc. | 706.79M | 9.41% | 291,521 | 10.84M |
| 199 | DRTS | Alpha Tau Medical Ltd. | 706.72M | 0.75% | 250,510 | - |
| 200 | ARVN | Arvinas, Inc. | 703.57M | - | 758,990 | 262.60M |
| 201 | PRME | Prime Medicine, Inc. | 674.67M | 3.81% | 1,904,698 | 4.63M |
| 202 | OCGN | Ocugen, Inc. | 672.42M | 3.11% | 5,192,082 | 4.41M |
| 203 | PROK | ProKidney Corp. | 658.18M | 11.79% | 1,380,353 | 893.00K |
| 204 | EIKN | Eikon Therapeutics, Inc. | 644.25M | 5.87% | 202,933 | - |
| 205 | ANL | Adlai Nortye Ltd. | 640.40M | 16.95% | 1,387,283 | 5.00M |
| 206 | ZVRA | Zevra Therapeutics, Inc. | 626.45M | 2.60% | 1,216,675 | 106.47M |
| 207 | KYTX | Kyverna Therapeutics, Inc. | 600.32M | 4.20% | 919,579 | - |
| 208 | RIGL | Rigel Pharmaceuticals, Inc. | 599.08M | 2.08% | 418,083 | 294.28M |
| 209 | ACRS | Aclaris Therapeutics, Inc. | 590.73M | 6.78% | 1,091,269 | 7.83M |
| 210 | PRTA | Prothena Corporation plc | 586.78M | 3.61% | 486,483 | 9.68M |
| 211 | CRMD | CorMedix Inc. | 584.18M | 3.65% | 1,263,953 | 311.71M |
| 212 | VSTM | Verastem, Inc. | 578.01M | 3.79% | 2,524,372 | 30.91M |
| 213 | STTK | Shattuck Labs, Inc. | 569.13M | 2.45% | 312,455 | 1.00M |
| 214 | LYEL | Lyell Immunopharma, Inc. | 560.11M | 1.31% | 93,784 | 36.00K |
| 215 | TECX | Tectonic Therapeutic, Inc. | 554.10M | -0.57% | 175,199 | - |
| 216 | AGMB | AgomAb Therapeutics NV | 552.19M | 1.16% | 296,150 | - |
| 217 | FULC | Fulcrum Therapeutics, Inc. | 552.12M | 3.75% | 1,037,200 | 80.00M |
| 218 | ZURA | Zura Bio Limited | 551.26M | 1.75% | 720,757 | - |
| 219 | IMMX | Immix Biopharma, Inc. | 548.68M | 3.92% | 1,045,109 | - |
| 220 | ABSI | Absci Corporation | 547.82M | 10.84% | 6,448,560 | 2.80M |
| 221 | ADCT | ADC Therapeutics SA | 543.75M | -2.28% | 544,604 | 81.36M |
| 222 | UPB | Upstream Bio, Inc. | 543.66M | -1.09% | 661,701 | 2.85M |
| 223 | ENGN | enGene Therapeutics Inc. | 540.60M | -0.12% | 842,967 | - |
| 224 | FDMT | 4D Molecular Therapeutics, Inc. | 535.53M | 4.27% | 894,694 | 85.21M |
| 225 | VALN | Valneva SE | 531.45M | -0.17% | 19,804 | 205.07M |
| 226 | STRO | Sutro Biopharma, Inc. | 522.70M | 7.50% | 296,978 | 102.48M |
| 227 | LXEO | Lexeo Therapeutics, Inc. | 511.94M | 5.02% | 654,351 | - |
| 228 | MDXG | MiMedx Group, Inc. | 507.35M | -0.44% | 1,995,838 | 418.63M |
| 229 | CTNM | Contineum Therapeutics, Inc. | 505.16M | 1.73% | 424,165 | - |
| 230 | TRDA | Entrada Therapeutics, Inc. | 503.64M | 3.17% | 113,329 | 25.42M |
| 231 | LRMR | Larimar Therapeutics, Inc. | 498.64M | 1.69% | 898,110 | - |
| 232 | IVVD | Invivyd, Inc. | 492.08M | 1.75% | 1,896,522 | 53.43M |
| 233 | RGNX | REGENXBIO Inc. | 489.85M | 3.26% | 454,365 | 170.44M |
| 234 | BNTC | Benitec Biopharma Inc. | 482.31M | 4.61% | 136,756 | - |
| 235 | XOMA | XOMA Royalty Corporation | 473.17M | 0.50% | 174,154 | 52.15M |
| 236 | VTVT | vTv Therapeutics Inc. | 473.05M | 3.73% | 30,440 | 17.00K |
| 237 | AURA | Aura Biosciences, Inc. | 467.66M | 3.26% | 427,522 | - |
| 238 | DNA | Ginkgo Bioworks Holdings, Inc. | 467.40M | 1.01% | 1,600,195 | 170.16M |
| 239 | IPSC | Century Therapeutics, Inc. | 467.28M | 6.56% | 1,905,909 | 109.16M |
| 240 | CADL | Candel Therapeutics, Inc. | 466.58M | 23.45% | 4,148,099 | - |
| 241 | ASMB | Assembly Biosciences, Inc. | 463.83M | -0.27% | 230,433 | 72.30M |
| 242 | AVIR | Atea Pharmaceuticals, Inc. | 457.32M | 0.70% | 427,715 | - |
| 243 | ALT | Altimmune, Inc. | 455.37M | -0.28% | 2,868,680 | 41.00K |
| 244 | EPRX | Eupraxia Pharmaceuticals Inc. | 438.18M | -1.39% | 85,764 | - |
| 245 | CLYM | Climb Bio, Inc. | 437.56M | 3.85% | 450,871 | - |
| 246 | PRTC | PureTech Health plc | 436.90M | 0.44% | 6,088 | 6.39M |
| 247 | NGNE | Neurogene Inc. | 433.74M | 8.66% | 325,840 | 925.00K |
| 248 | VNDA | Vanda Pharmaceuticals Inc. | 429.72M | 1.54% | 1,062,614 | 216.11M |
| 249 | RCKT | Rocket Pharmaceuticals, Inc. | 426.67M | 0.26% | 2,036,196 | - |
| 250 | LCTX | Lineage Cell Therapeutics, Inc. | 425.94M | 4.27% | 1,993,955 | 14.56M |
| 251 | AUTL | Autolus Therapeutics plc | 425.83M | -0.62% | 2,137,287 | 75.39M |
| 252 | ARMP | Armata Pharmaceuticals, Inc. | 421.28M | 1.05% | 35,966 | 4.90M |
| 253 | IRD | Opus Genetics, Inc. | 409.11M | - | 747,938 | 14.20M |
| 254 | ENTA | Enanta Pharmaceuticals, Inc. | 406.56M | -0.36% | 123,144 | 66.98M |
| 255 | PALI | Palisade Bio, Inc. | 401.81M | 3.00% | 3,536,844 | - |
| 256 | NMRA | Neumora Therapeutics, Inc. | 391.39M | 7.50% | 1,416,725 | - |
| 257 | XFOR | X4 Pharmaceuticals, Inc. | 390.05M | 3.62% | 301,235 | 35.11M |
| 258 | NAGE | Niagen Bioscience, Inc. | 388.40M | 2.33% | 875,229 | 129.42M |
| 259 | AVTX | Avalo Therapeutics, Inc. | 385.49M | 0.07% | 829,663 | 59.00K |
| 260 | GLSI | Greenwich LifeSciences, Inc. | 384.32M | 2.36% | 240,646 | - |
| 261 | OVID | Ovid Therapeutics Inc. | 383.76M | 3.93% | 2,379,035 | 7.25M |
| 262 | NAUT | Nautilus Biotechnology, Inc. | 383.49M | -3.04% | 204,004 | - |
| 263 | CABA | Cabaletta Bio, Inc. | 382.95M | -2.27% | 3,364,579 | - |
| 264 | YDES | YD Bio Limited | 382.54M | 2.64% | 86,375 | 510.36K |
| 265 | PBYI | Puma Biotechnology, Inc. | 380.05M | 3.18% | 264,398 | 228.37M |
| 266 | MNPR | Monopar Therapeutics Inc. | 376.23M | -2.56% | 244,240 | - |
| 267 | BCYC | Bicycle Therapeutics plc | 371.54M | 3.70% | 280,775 | 72.59M |
| 268 | DMAC | DiaMedica Therapeutics Inc. | 369.10M | 3.47% | 212,284 | - |
| 269 | PRLD | Prelude Therapeutics Incorporated | 366.45M | 0.23% | 367,357 | 12.14M |
| 270 | SRZN | Surrozen, Inc. | 362.52M | 4.09% | 133,114 | 3.48M |
| 271 | IMRX | Immuneering Corporation | 359.47M | -0.18% | 823,160 | - |
| 272 | RZLT | Rezolute, Inc. | 359.40M | -2.26% | 1,108,602 | - |
| 273 | SLN | Silence Therapeutics plc | 355.67M | -0.92% | 416,538 | 559.00K |
| 274 | EDIT | Editas Medicine, Inc. | 341.57M | 4.18% | 1,638,458 | 40.52M |
| 275 | AVXL | Anavex Life Sciences Corp. | 337.33M | 7.06% | 1,541,672 | - |
| 276 | NGEN | NervGen Pharma Corp. | 329.39M | -2.16% | 103,100 | - |
| 277 | ZNTL | Zentalis Pharmaceuticals, Inc. | 329.12M | -7.57% | 2,296,649 | 26.87M |
| 278 | CLLS | Cellectis S.A. | 324.09M | 3.51% | 73,352 | 79.59M |
| 279 | LENZ | LENZ Therapeutics, Inc. | 319.19M | 5.60% | 567,466 | 19.09M |
| 280 | ABEO | Abeona Therapeutics Inc. | 313.77M | 2.23% | 920,871 | 5.82M |
| 281 | NBP | NovaBridge Biosciences | 312.25M | 1.12% | 1,109,294 | - |
| 282 | IKT | Inhibikase Therapeutics, Inc. | 311.87M | 7.65% | 1,620,279 | 1.00 |
| 283 | FHTX | Foghorn Therapeutics Inc. | 310.52M | 8.85% | 153,659 | 30.91M |
| 284 | ARTV | Artiva Biotherapeutics, Inc. | 310.19M | 3.63% | 746,258 | 251.00K |
| 285 | CHRS | Coherus Oncology, Inc. | 305.35M | 4.21% | 1,754,930 | 42.17M |
| 286 | ELDN | Eledon Pharmaceuticals, Inc. | 302.35M | 6.70% | 4,471,265 | - |
| 287 | ACIU | AC Immune SA | 298.60M | -1.95% | 266,259 | 4.51M |
| 288 | NERV | Minerva Neurosciences, Inc. | 295.06M | 7.00% | 264,746 | - |
| 289 | TARA | Protara Therapeutics, Inc. | 294.22M | 6.04% | 719,081 | - |
| 290 | PLYX | Polaryx Therapeutics, Inc. | 289.74M | -4.23% | 85,236 | - |
| 291 | CCCC | C4 Therapeutics, Inc. | 284.93M | 0.69% | 1,139,443 | 35.95M |
| 292 | ALEC | Alector, Inc. | 283.63M | 0.78% | 343,059 | 21.05M |
| 293 | HELP | Cybin Inc. | 275.20M | - | 988,225 | - |
| 294 | ACHV | Achieve Life Sciences, Inc. | 271.52M | 6.03% | 4,213,566 | - |
| 295 | SABS | SAB Biotherapeutics, Inc. | 270.56M | -1.79% | 346,049 | 114.70K |
| 296 | OBIO | Orchestra BioMed Holdings, Inc. | 268.03M | 2.46% | 128,372 | 33.48M |
| 297 | CGEN | Compugen Ltd. | 266.64M | -2.42% | 660,257 | 72.76M |
| 298 | ADAG | Adagene Inc. | 262.31M | 3.12% | 279,359 | 7.67M |
| 299 | MIST | Milestone Pharmaceuticals Inc. | 257.56M | 0.48% | 1,346,597 | 1.55M |
| 300 | ARCT | Arcturus Therapeutics Holdings Inc. | 251.54M | 0.11% | 499,652 | 82.03M |
| 301 | ELTX | Elicio Therapeutics, Inc. | 249.27M | 7.54% | 375,245 | - |
| 302 | NKTX | Nkarta, Inc. | 247.38M | 23.93% | 3,162,327 | - |
| 303 | VYGR | Voyager Therapeutics, Inc. | 246.15M | 4.29% | 860,886 | 40.37M |
| 304 | SLGL | Sol-Gel Technologies Ltd. | 241.48M | -1.69% | 40,580 | 19.39M |
| 305 | OABI | OmniAb, Inc. | 237.44M | 5.13% | 617,665 | 18.67M |
| 306 | NVCT | Nuvectis Pharma, Inc. | 235.78M | 6.59% | 92,743 | - |
| 307 | CDXS | Codexis, Inc. | 235.35M | 1.97% | 1,419,626 | 70.39M |
| 308 | FENC | Fennec Pharmaceuticals Inc. | 234.09M | 7.78% | 216,526 | 44.64M |
| 309 | CAMP | Camp4 Therapeutics Corporation | 233.12M | -0.22% | 150,726 | 3.50M |
| 310 | KROS | Keros Therapeutics, Inc. | 230.10M | -0.43% | 370,637 | 244.06M |
| 311 | MDWD | MediWound Ltd. | 227.74M | 3.63% | 90,763 | 16.96M |
| 312 | CNTX | Context Therapeutics Inc. | 223.27M | 6.11% | 1,203,947 | - |
| 313 | MGNX | MacroGenics, Inc. | 219.92M | 1.47% | 528,964 | 149.50M |
| 314 | ALXO | ALX Oncology Holdings Inc. | 219.79M | -0.60% | 1,834,779 | - |
| 315 | CRBU | Caribou Biosciences, Inc. | 212.60M | 2.33% | 1,808,590 | 11.16M |
| 316 | SGMT | Sagimet Biosciences Inc. | 210.83M | 4.52% | 624,767 | - |
| 317 | PRQR | ProQR Therapeutics N.V. | 209.67M | 2.05% | 608,537 | 19.19M |
| 318 | KRRO | Korro Bio, Inc. | 207.54M | 6.83% | 87,197 | 6.39M |
| 319 | ENLV | Enlivex Ltd. | 204.03M | -3.27% | 407,869 | - |
| 320 | ABOS | Acumen Pharmaceuticals, Inc. | 203.64M | 4.83% | 441,233 | - |
| 321 | DTIL | Precision BioSciences, Inc. | 203.33M | 4.65% | 251,655 | 34.26M |
| 322 | TNXP | Tonix Pharmaceuticals Holding Corp. | 198.59M | -1.06% | 373,743 | 13.11M |
| 323 | CNTN | Canton Strategic Holdings, Inc. | 194.33M | -1.72% | 1,096,653 | - |
| 324 | KPTI | Karyopharm Therapeutics Inc. | 194.10M | -0.58% | 165,482 | 146.07M |
| 325 | WHWK | Whitehawk Therapeutics, Inc. | 193.98M | -2.84% | 571,543 | 7.15M |
| 326 | HRTX | Heron Therapeutics, Inc. | 188.54M | 6.38% | 2,630,943 | 154.90M |
| 327 | CRBP | Corbus Pharmaceuticals Holdings, Inc. | 187.83M | 4.44% | 546,339 | - |
| 328 | MENS | Jyong Biotech Ltd. | 187.64M | -5.79% | 194,999 | - |
| 329 | PLX | Protalix BioTherapeutics, Inc. | 186.93M | 0.87% | 536,470 | 52.74M |
| 330 | RNAC | Cartesian Therapeutics, Inc. | 186.62M | 10.34% | 373,252 | 2.80M |
| 331 | HURA | TuHURA Biosciences, Inc. | 185.65M | -1.35% | 1,553,860 | - |
| 332 | AGEN | Agenus Inc. | 183.93M | 3.23% | 827,402 | 114.20M |
| 333 | REPL | Replimune Group, Inc. | 179.18M | -0.91% | 5,934,401 | - |
| 334 | UNCY | Unicycive Therapeutics, Inc. | 177.17M | 1.74% | 391,724 | - |
| 335 | BDTX | Black Diamond Therapeutics, Inc. | 175.30M | 4.79% | 998,238 | 70.00M |
| 336 | TNYA | Tenaya Therapeutics, Inc. | 169.71M | 4.68% | 3,317,452 | - |
| 337 | FATE | Fate Therapeutics, Inc. | 161.61M | 1.46% | 2,024,528 | 6.65M |
| 338 | GALT | Galectin Therapeutics Inc. | 161.28M | 8.41% | 540,430 | - |
| 339 | BMEA | Biomea Fusion, Inc. | 159.78M | 14.51% | 3,436,788 | - |
| 340 | SPRO | Spero Therapeutics, Inc. | 159.20M | 2.61% | 381,176 | 66.80M |
| 341 | CNTB | Connect Biopharma Holdings Limited | 158.82M | -6.02% | 382,788 | 64.00K |
| 342 | TLSA | Tiziana Life Sciences Ltd | 158.25M | -7.46% | 327,950 | - |
| 343 | HUMA | Humacyte, Inc. | 157.68M | 3.89% | 5,062,002 | 2.04M |
| 344 | MOLN | Molecular Partners AG | 156.96M | - | 2,654 | 856.30K |
| 345 | ORMP | Oramed Pharmaceuticals Inc. | 156.93M | 0.52% | 87,732 | 2.00M |
| 346 | IPHA | Innate Pharma S.A. | 152.35M | 2.47% | 51,871 | 10.57M |
| 347 | ACOG | Alpha Cognition Inc. | 151.11M | 4.36% | 62,303 | 10.22M |
| 348 | KLRS | Kalaris Therapeutics, Inc. | 144.91M | -4.10% | 105,994 | - |
| 349 | NTHI | NeOnc Technologies Holdings, Inc. | 134.02M | 7.17% | 23,354 | 39.99K |
| 350 | IMUX | Immunic, Inc. | 130.46M | - | 3,309,477 | - |
| 351 | ONCY | Oncolytics Biotech Inc. | 130.06M | 5.66% | 1,050,058 | - |
| 352 | ANTX | AN2 Therapeutics, Inc. | 129.91M | 14.97% | 506,217 | - |
| 353 | EQ | Equillium, Inc. | 129.61M | 3.54% | 156,596 | 4.39M |
| 354 | KZIA | Kazia Therapeutics Limited | 126.84M | 1.65% | 410,207 | 1.27M |
| 355 | GNLX | Genelux Corporation | 123.80M | 0.72% | 135,658 | 8.00K |
| 356 | CRDF | Cardiff Oncology, Inc. | 123.06M | 6.51% | 1,272,893 | 593.00K |
| 357 | CBUS | Cibus, Inc. | 121.11M | 11.19% | 595,731 | 3.64M |
| 358 | PEPG | PepGen Inc. | 117.50M | 1.80% | 939,163 | - |
| 359 | IFRX | InflaRx N.V. | 114.95M | 32.50% | 7,935,205 | 34.44K |
| 360 | AARD | Aardvark Therapeutics, Inc. | 114.10M | 4.81% | 213,933 | - |
| 361 | VANI | Vivani Medical, Inc. | 113.43M | 2.29% | 464,509 | - |
| 362 | SEER | Seer, Inc. | 112.84M | -2.44% | 537,221 | 16.58M |
| 363 | COYA | Coya Therapeutics, Inc. | 112.13M | 6.70% | 219,752 | 7.95M |
| 364 | VRCA | Verrica Pharmaceuticals Inc. | 108.57M | 1.77% | 102,259 | 35.58M |
| 365 | SGMO | Sangamo Therapeutics, Inc. | 108.54M | -2.96% | 3,127,081 | 39.55M |
| 366 | ALDX | Aldeyra Therapeutics, Inc. | 108.33M | - | 1,301,807 | - |
| 367 | CGTX | Cognition Therapeutics, Inc. | 106.33M | 7.21% | 1,291,497 | - |
| 368 | GOSS | Gossamer Bio, Inc. | 104.67M | 1.97% | 4,082,759 | 48.47M |
| 369 | PYXS | Pyxis Oncology, Inc. | 104.30M | -2.35% | 337,771 | 13.86M |
| 370 | PMN | ProMIS Neurosciences, Inc. | 103.40M | -2.62% | 35,532 | - |
| 371 | TTRX | Turn Therapeutics Inc. | 103.07M | 1.17% | 63,220 | - |
| 372 | ANIX | Anixa Biosciences, Inc. | 97.57M | 2.83% | 91,285 | - |
| 373 | INO | Inovio Pharmaceuticals, Inc. | 97.51M | 2.59% | 2,034,120 | 65.34K |
| 374 | SPRB | Spruce Biosciences, Inc. | 96.47M | 3.53% | 32,042 | 697.00K |
| 375 | RANI | Rani Therapeutics Holdings, Inc. | 95.37M | 4.07% | 1,305,207 | 1.63M |
| 376 | COEP | Coeptis Therapeutics Holdings, Inc. | 91.17M | 6.86% | 47,117 | 1.36M |
| 377 | PYPD | PolyPid Ltd. | 90.45M | 1.72% | 63,083 | - |
| 378 | GUTS | Fractyl Health, Inc. | 90.33M | 10.69% | 3,030,452 | 3.00K |
| 379 | GANX | Gain Therapeutics, Inc. | 89.98M | 3.90% | 681,694 | - |
| 380 | EXOZ | eXoZymes, Inc. | 89.88M | 0.95% | 1,617 | -700.00 |
| 381 | ACET | Adicet Bio, Inc. | 88.36M | 2.11% | 187,402 | - |
| 382 | OKYO | OKYO Pharma Limited | 87.12M | 4.40% | 79,087 | - |
| 383 | QTTB | Q32 Bio Inc. | 85.58M | 2.27% | 791,717 | 53.74M |
| 384 | MCRB | Seres Therapeutics, Inc. | 85.22M | 0.68% | 105,169 | 789.00K |
| 385 | NRXP | NRx Pharmaceuticals, Inc. | 84.24M | 1.59% | 1,086,078 | 1.23M |
| 386 | CSBR | Champions Oncology, Inc. | 83.81M | -1.07% | 1,424 | 57.95M |
| 387 | ATYR | aTyr Pharma, Inc. | 83.68M | 2.76% | 700,915 | 190.00K |
| 388 | FLNA | Filana Therapeutics, Inc. | 83.57M | -1.70% | 462,918 | - |
| 389 | LONA | LeonaBio, Inc. | 83.23M | 7.65% | 42,035 | - |
| 390 | PLRX | Pliant Therapeutics, Inc. | 82.35M | 2.31% | 444,462 | - |
| 391 | MAIA | MAIA Biotechnology, Inc. | 81.91M | 1.50% | 852,159 | - |
| 392 | NRXS | NeurAxis, Inc. | 80.77M | -1.90% | 235,306 | 3.57M |
| 393 | ESLA | Estrella Immunopharma, Inc. | 80.21M | 13.25% | 71,098 | - |
| 394 | ATHE | Alterity Therapeutics Limited | 78.18M | 12.59% | 56,839 | 4.43M |
| 395 | PTHS | Pelthos Therapeutics Inc. | 77.23M | 0.07% | 16,714 | 16.80M |
| 396 | FBIO | Fortress Biotech, Inc. | 76.00M | 0.43% | 419,945 | 63.26M |
| 397 | XBIT | XBiotech Inc. | 75.00M | 1.23% | 54,108 | - |
| 398 | PMVP | PMV Pharmaceuticals, Inc. | 73.59M | 0.73% | 493,859 | - |
| 399 | PDSB | PDS Biotechnology Corporation | 73.12M | 2.34% | 728,847 | - |
| 400 | IMMP | Immutep Limited | 73.10M | 0.76% | 12,139,211 | 5.28M |
| 401 | ICCC | ImmuCell Corporation | 72.19M | 5.84% | 46,675 | 27.64M |
| 402 | TCRX | TScan Therapeutics, Inc. | 71.52M | 10.19% | 1,304,590 | 10.33M |
| 403 | MNOV | MediciNova, Inc. | 71.37M | 0.69% | 17,785 | 409.66K |
| 404 | GRCE | Grace Therapeutics, Inc. | 71.18M | 2.45% | 1,000,784 | - |
| 405 | IBIO | iBio, Inc. | 71.16M | -2.37% | 776,267 | 300.00K |
| 406 | BYSI | BeyondSpring Inc. | 71.14M | 2.98% | 3,163 | 1.88M |
| 407 | INKT | MiNK Therapeutics, Inc. | 70.56M | 0.57% | 152,144 | - |
| 408 | IBO | Impact BioMedical Inc. | 69.54M | -2.73% | 109,798 | 32.00K |
| 409 | ACRV | Acrivon Therapeutics, Inc. | 68.97M | 6.59% | 603,416 | - |
| 410 | OKUR | OnKure Therapeutics, Inc. | 68.37M | 7.07% | 298,650 | - |
| 411 | HYFT | MindWalk Holdings Corp. | 66.06M | 0.76% | 363,915 | 20.70M |
| 412 | IMA | ImageneBio, Inc. | 65.99M | 2.08% | 67,157 | 800.00K |
| 413 | ANVS | Annovis Bio, Inc. | 64.58M | 5.06% | 1,078,173 | - |
| 414 | CING | Cingulate Inc. | 63.38M | 3.61% | 273,195 | - |
| 415 | TIL | Instil Bio, Inc. | 60.22M | 0.39% | 18,118 | - |
| 416 | ENTX | Entera Bio Ltd. | 59.68M | 6.67% | 1,953,662 | 42.00K |
| 417 | CUE | Cue Biopharma, Inc. | 59.20M | -1.46% | 2,913,065 | 27.47M |
| 418 | OSTX | OS Therapies Incorporated | 58.43M | -0.71% | 769,119 | - |
| 419 | MGX | Metagenomi Therapeutics, Inc. | 55.68M | 2.78% | 315,795 | 25.21M |
| 420 | DWTX | Dogwood Therapeutics, Inc. | 55.45M | 6.41% | 198,415 | - |
| 421 | ACTU | Actuate Therapeutics, Inc. | 54.77M | 7.44% | 66,442 | - |
| 422 | KZR | Kezar Life Sciences, Inc. | 54.03M | -0.54% | 66,485 | - |
| 423 | MREO | Mereo BioPharma Group plc | 53.73M | 3.16% | 2,124,613 | 500.00K |
| 424 | EDSA | Edesa Biotech, Inc. | 52.69M | 15.37% | 259,631 | - |
| 425 | NTRB | Nutriband Inc. | 52.27M | 5.13% | 16,247 | 2.28M |
| 426 | RADX | Radiopharm Theranostics Limited | 52.23M | -1.29% | 32,533 | 10.86M |
| 427 | HYPD | Hyperion DeFi, Inc. | 50.81M | 14.07% | 878,062 | 813.46K |
| 428 | ATOS | Atossa Therapeutics, Inc. | 50.20M | 1.04% | 54,649 | - |
| 429 | TELO | Telomir Pharmaceuticals, Inc. | 49.85M | 8.21% | 187,140 | - |
| 430 | XLO | Xilio Therapeutics, Inc. | 49.56M | 2.63% | 40,360 | 43.77M |
| 431 | RNTX | Rein Therapeutics Inc. | 49.35M | 3.53% | 56,266 | - |
| 432 | HOWL | Werewolf Therapeutics, Inc. | 45.96M | 3.74% | 215,587 | 1.14M |
| 433 | RNXT | RenovoRx, Inc. | 45.05M | - | 257,712 | 1.12M |
| 434 | PSTV | Plus Therapeutics, Inc. | 43.85M | 7.39% | 263,080 | 5.21M |
| 435 | RLYB | Rallybio Corporation | 43.48M | -1.32% | 32,655 | 858.00K |
| 436 | ATRA | Atara Biotherapeutics, Inc. | 43.10M | 0.57% | 76,213 | 120.77M |
| 437 | DARE | Daré Bioscience, Inc. | 42.95M | 8.46% | 9,915,768 | 1.03M |
| 438 | LITS | Lite Strategy, Inc. | 42.91M | - | 367,321 | - |
| 439 | LIXT | Lixte Biotechnology Holdings, Inc. | 41.94M | 12.11% | 29,674 | - |
| 440 | ALGS | Aligos Therapeutics, Inc. | 41.33M | -12.79% | 829,864 | 2.19M |
| 441 | SNSE | Sensei Biotherapeutics, Inc. | 40.87M | 4.35% | 25,552 | - |
| 442 | ATNM | Actinium Pharmaceuticals, Inc. | 40.53M | 4.00% | 200,841 | 90.00K |
| 443 | CVM | CEL-SCI Corporation | 40.06M | 6.68% | 53,328 | - |
| 444 | VERU | Veru Inc. | 39.16M | -1.21% | 67,622 | 16.89M |
| 445 | INMB | INmune Bio Inc. | 38.55M | 8.21% | 406,295 | 50.00K |
| 446 | PASG | Passage Bio, Inc. | 37.44M | -0.09% | 20,351 | - |
| 447 | EVAX | Evaxion A/S | 37.11M | 7.49% | 119,879 | 7.53M |
| 448 | CRVO | CervoMed Inc. | 36.85M | -0.25% | 20,181 | 4.01M |
| 449 | NXTC | NextCure, Inc. | 36.76M | -6.14% | 52,590 | - |
| 450 | PLUR | Pluri Inc. | 36.38M | 3.13% | 1,923 | 1.34M |
| 451 | CELU | Celularity Inc. | 35.47M | -0.81% | 30,162 | 40.58M |
| 452 | BOLD | Boundless Bio, Inc. | 35.40M | -3.07% | 352,286 | - |
| 453 | PTN | Palatin Technologies, Inc. | 35.00M | 7.66% | 18,911 | 8.96M |
| 454 | SNTI | Senti Biosciences, Inc. | 34.26M | 14.38% | 946,752 | 22.00K |
| 455 | ABVC | ABVC BioPharma, Inc. | 32.62M | 7.32% | 106,510 | 797.92K |
| 456 | OTLK | Outlook Therapeutics, Inc. | 32.35M | 14.35% | 4,673,469 | 205.70K |
| 457 | BCTX | BriaCell Therapeutics Corp. | 32.30M | 2.55% | 118,362 | - |
| 458 | LGVN | Longeveron Inc. | 32.21M | - | 920,172 | 1.20M |
| 459 | IGC | IGC Pharma, Inc. | 32.19M | 4.64% | 739,663 | 1.11M |
| 460 | DYAI | Dyadic International, Inc. | 31.88M | -0.23% | 56,468 | 3.09M |
| 461 | TVRD | Tvardi Therapeutics, Inc. | 31.80M | 5.28% | 35,912 | - |
| 462 | TVGN | Tevogen Bio Holdings Inc. | 30.73M | 16.04% | 28,025 | - |
| 463 | APLM | Apollomics, Inc. | 29.84M | -2.59% | 8,667 | 6.93M |
| 464 | KYNB | Kyntra Bio, Inc. | 29.62M | 1.81% | 4,054 | 6.44M |
| 465 | NNVC | NanoViricides, Inc. | 29.59M | 18.10% | 659,007 | - |
| 466 | LSTA | Lisata Therapeutics, Inc. | 29.17M | -4.15% | 107,464 | 170.00K |
| 467 | JSPR | Jasper Therapeutics, Inc. | 28.56M | 5.60% | 457,199 | - |
| 468 | TPST | Tempest Therapeutics, Inc. | 28.11M | -12.50% | 498,115 | - |
| 469 | LTRN | Lantern Pharma Inc. | 27.91M | -1.97% | 230,627 | - |
| 470 | MRKR | Marker Therapeutics, Inc. | 27.68M | 3.11% | 178,850 | 3.55M |
| 471 | SKYE | Skye Bioscience, Inc. | 26.33M | 5.19% | 242,240 | - |
| 472 | AEON | AEON Biopharma, Inc. | 25.81M | 3.24% | 190,267 | - |
| 473 | NEUP | Neuphoria Therapeutics Inc. | 25.71M | 1.06% | 39,183 | 14.99M |
| 474 | LEXX | Lexaria Bioscience Corp. | 25.53M | 4.57% | 352,395 | 368.00K |
| 475 | SER | Serina Therapeutics, Inc. | 25.24M | 3.02% | 144,688 | 130.00K |
| 476 | NRSN | NeuroSense Therapeutics Ltd. | 24.99M | -0.14% | 152,531 | - |
| 477 | VTGN | Vistagen Therapeutics, Inc. | 24.87M | 4.08% | 1,191,767 | 789.00K |
| 478 | XCUR | Exicure, Inc. | 24.14M | -1.81% | 6,763 | 500.00K |
| 479 | CRIS | Curis, Inc. | 24.11M | 2.01% | 1,142,048 | 9.44M |
| 480 | BRNS | Barinthus Biotherapeutics plc | 24.10M | -0.17% | 14,995 | 14.97M |
| 481 | QNCX | Quince Therapeutics, Inc. | 22.33M | 2.24% | 2,777,128 | - |
| 482 | COCP | Cocrystal Pharma, Inc. | 20.82M | -3.82% | 383,865 | - |
| 483 | PLRZ | Polyrizon Ltd. | 20.34M | 4.30% | 62,872 | - |
| 484 | VYNE | VYNE Therapeutics Inc. | 20.33M | -1.21% | 184,938 | 570.00K |
| 485 | ALLR | Allarity Therapeutics, Inc. | 19.46M | -0.81% | 59,148 | 320.00K |
| 486 | CTXR | Citius Pharmaceuticals, Inc. | 19.21M | 0.39% | 438,126 | 3.94M |
| 487 | OSRH | OSR Holdings, Inc. | 18.88M | 3.45% | 548,072 | 2.91M |
| 488 | KTTA | Pasithea Therapeutics Corp. | 18.52M | 0.87% | 213,399 | - |
| 489 | QNTM | Quantum BioPharma Ltd. | 18.46M | -1.58% | 155,931 | - |
| 490 | LPCN | Lipocine Inc. | 17.74M | -5.08% | 735,935 | 1.98M |
| 491 | TRAW | Traws Pharma, Inc. | 17.47M | 3.31% | 379,070 | 2.79M |
| 492 | PBM | Psyence Biomedical Ltd. | 17.43M | 29.47% | 50,469,276 | - |
| 493 | GNTA | Genenta Science S.p.A. | 17.22M | 1.00% | 39,428 | - |
| 494 | ICU | SeaStar Medical Holding Corporation | 16.77M | 0.96% | 263,260 | 1.23M |
| 495 | JUNS | Jupiter Neurosciences, Inc. | 15.86M | 9.63% | 355,188 | 21.80K |
| 496 | HIND | Vyome Holdings, Inc. | 15.51M | -0.45% | 21,481 | 319.71K |
| 497 | PHIO | Phio Pharmaceuticals Corp. | 14.99M | 1.57% | 102,902 | - |
| 498 | INAB | IN8bio, Inc. | 14.18M | -0.69% | 18,617 | - |
| 499 | HOTH | Hoth Therapeutics, Inc. | 13.96M | -1.78% | 983,850 | - |
| 500 | INTS | Intensity Therapeutics, Inc. | 13.46M | -0.38% | 59,674 | - |